NYSE : COR
Cencora, Inc. — Key statistics
Healthcare · Medical Distribution · United States
Last price 330.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 63.13B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 63.13B |
| Enterprise Value | 74.78B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 190.83M |
| Shares Outstanding | 190.83M |
| Shares Change (YoY) | -0.46% |
| Shares Change (QoQ) | -0.74% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 97.12% |
| Float | 180.25M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 24.58 |
| Forward PE | 17.12 |
| PS Ratio | 0.19 |
| Forward PS | 0.18 |
| PB Ratio | 20.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.55 |
| P/OCF Ratio | 13.10 |
| PEG Ratio | 1.76 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 28.49 |
| EV / Sales | 0.22 |
| EV / EBITDA | 13.48 |
| EV / EBIT | 16.65 |
| EV / FCF | 18.42 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.93 |
| Quick Ratio | 0.48 |
| Debt / Equity | 4.47 |
| Debt / EBITDA | 2.44 |
| Debt / FCF | 3.56 |
| Interest Coverage | 8.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 96.87% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 20.95% |
| Return on Capital Employed (ROCE) | 18.25% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | $6.52M |
| Profits Per Employee | $51,467 |
| Employee Count | 51,000 |
| Asset Turnover | 4.22 |
| Inventory Turnover | 15.53 |
Taxes
| Measure | Value |
|---|
| Income Tax | 967.31M |
| Effective Tax Rate | 26.82% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -0.70% |
| 50-Day Moving Average | 323.38 |
| 200-Day Moving Average | 317.09 |
| Relative Strength Index (RSI) | 54.14 |
| Average Volume (20 Days) | 1,133,908 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.93M |
| Short Previous Month | 4.31M |
| Short % of Shares Out | 2.06% |
| Short % of Float | 2.18% |
| Short Ratio (days to cover) | 3.16 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 332.77B |
| Gross Profit | 13.18B |
| Operating Income | 4.49B |
| Pretax Income | 3.61B |
| Net Income | 2.62B |
| EBITDA | 5.55B |
| EBIT | 4.49B |
| Earnings Per Share (EPS) | $13.46 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.82B |
| Total Debt | 14.46B |
| Net Cash | -11.65B |
| Net Cash Per Share | -$61.04 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 15.99 |
| Working Capital | -3.86B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.82B |
| Capital Expenditures | -760.85M |
| Depreciation & Amortization | 1.05B |
| Net Borrowing | 3.15B |
| Free Cash Flow | 4.06B |
| FCF Per Share | $21.28 |
Margins
| Measure | Value |
|---|
| Gross Margin | 3.96% |
| Operating Margin | 1.35% |
| Pretax Margin | 1.08% |
| Profit Margin | 0.79% |
| EBITDA Margin | 1.67% |
| EBIT Margin | 1.35% |
| FCF Margin | 1.22% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.73% |
| Dividend Growth (YoY) | 9.09% |
| Years of Dividend Growth | 21 |
| Payout Ratio | 17.83% |
| FCF Payout Ratio | 11.28% |
| Buyback Yield | 0.46% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 4.07% |
| FCF Yield | 6.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $371.67 |
| Price Target Difference | 12.34% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 4.63% |
| EPS Growth Forecast (3Y) | 11.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 16, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.7 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |